We also measured the OS time according to SPRR3 expression levels in glioma patients through Kaplan-Meier survival estimates; however, the results revealed that there was no significant correlation between the two subgroups with high or low SPRR3 expression (high expression, ≥2; low expression, <2). The gene discussed is SPRR3; the disease is central nervous system cancer.